Skip to main content
. 2017 Nov 8;15(1):739–744. doi: 10.3892/etm.2017.5471

Figure 4.

Figure 4.

Changes in serum AT-III concentration and urine protein. Serum AT-III concentration in the (A) rivaroxaban and (B) LWMH groups. Urine protein in the (C) rivaroxaban group and (D) LWMH groups. AT-III, antithrombin III; LWMH, low weight molecular heparin.